Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera
Sign Up to like & getrecommendations! Published in 2022 at "JCI Insight"
DOI: 10.1172/jci.insight.160173
Abstract: Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus responsible for numerous outbreaks. Chikungunya can cause debilitating acute and chronic disease. Thus, the development of a safe and effective CHIKV vaccine is an urgent global health… read more here.
Keywords: vla1553; passive transfer; chikv vaccine; chikv ... See more keywords